Avita Medical | Gewinn Vor Steuern

Aktienkurs
1.09
Täglich Wechseln
-0.05 -3.96%
Monatlich
4.31%
Jährlich
-62.67%
Q1 Prognose
1.19




Gewinn Vor Steuern Veränderung Datum
Celltrion KRW 14.6B 180.89B 2025-06
Clinuvel Pharmaceuticals AUD 35.87M 21.07M 2024-06
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 1.4B 1.14B 2025-06
Cspc Pharmaceutical CNY 1.21B 110.04M 2025-09
Dianthus Therapeutics USD -36.76M 5.13M 2025-09
Divis Laboratories Ltd INR 9.12B 1.79B 2025-09
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Mayne Pharma AUD -14.7M 42.91M 2024-12
Medical Developments International AUD -149K 466K 2025-06
Nanosonics AUD 11.39M 487K 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pacific Edge NZD -714K 49K 2024-03
Pharma Mar EUR -4.08M 27.43M 2025-09
Polynovo AUD 1.82M 3.89M 2025-06
PYC Therapeutics AUD -12.57M 13.3M 2025-06
Qiagen NV USD 134.73M 7.91M 2025-09
Ramsay Health Care AUD 103.75M 54.35M 2025-06
ResMed USD 496.15M 13.77M 2025-12
Sartorius EUR 85M 14.1M 2025-09
Telix Pharmaceuticals AUD 76.73M 66.04M 2025-06
Tilray USD -1.39B 600.71M 2025-03
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06


Avita Medical Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.